MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32 | -30.4% | 2,000 | 0.0% | 0.04% | -29.4% |
| Q2 2023 | $46 | 0.0% | 2,000 | 0.0% | 0.05% | -10.5% |
| Q1 2023 | $46 | +58.6% | 2,000 | 0.0% | 0.06% | +58.3% |
| Q4 2022 | $29 | -99.9% | 2,000 | 0.0% | 0.04% | -25.0% |
| Q3 2022 | $38,000 | +5.6% | 2,000 | 0.0% | 0.05% | +9.1% |
| Q2 2022 | $36,000 | -28.0% | 2,000 | 0.0% | 0.04% | -17.0% |
| Q1 2022 | $50,000 | -9.1% | 2,000 | 0.0% | 0.05% | -5.4% |
| Q4 2021 | $55,000 | -15.4% | 2,000 | 0.0% | 0.06% | -22.2% |
| Q3 2021 | $65,000 | +6.6% | 2,000 | 0.0% | 0.07% | +16.1% |
| Q2 2021 | $61,000 | 0.0% | 2,000 | 0.0% | 0.06% | +19.2% |
| Q1 2021 | $61,000 | +52.5% | 2,000 | 0.0% | 0.05% | +57.6% |
| Q4 2020 | $40,000 | +53.8% | 2,000 | 0.0% | 0.03% | +32.0% |
| Q3 2020 | $26,000 | +13.0% | 2,000 | 0.0% | 0.02% | +19.0% |
| Q2 2020 | $23,000 | -20.7% | 2,000 | 0.0% | 0.02% | -30.0% |
| Q1 2020 | $29,000 | -46.3% | 2,000 | 0.0% | 0.03% | -30.2% |
| Q4 2019 | $54,000 | -5.3% | 2,000 | 0.0% | 0.04% | -8.5% |
| Q3 2019 | $57,000 | +1.8% | 2,000 | 0.0% | 0.05% | +6.8% |
| Q2 2019 | $56,000 | -15.2% | 2,000 | 0.0% | 0.04% | -17.0% |
| Q1 2019 | $66,000 | +13.8% | 2,000 | 0.0% | 0.05% | +3.9% |
| Q4 2018 | $58,000 | -37.0% | 2,000 | 0.0% | 0.05% | -26.1% |
| Q3 2018 | $92,000 | +22.7% | 2,000 | 0.0% | 0.07% | +25.5% |
| Q2 2018 | $75,000 | +27.1% | 2,000 | 0.0% | 0.06% | +14.6% |
| Q1 2018 | $59,000 | -14.5% | 2,000 | 0.0% | 0.05% | -9.4% |
| Q4 2017 | $69,000 | – | 2,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |